EPO and Hypertension: Third, we used this variant in drug-target MR tests as a genetic predictor for therapeutically altered EPO levels to help inform the long-term effects of elevated endogenous EPO levels on risk of cardiovascular disease (CVD) or clinical markers (blood pressure and resting heart rate) predisposing to CVD risk factors (e.g., hypertension).